| scholarly article | Q13442814 |
| P50 | author | Janusz Edward Kasperczyk | Q17544572 |
| Katarzyna Jelonek | Q61946998 | ||
| Adam Wilczok | Q70270614 | ||
| Alicja Zajdel | Q78064653 | ||
| Monika Musiał-Kulik | Q87222608 | ||
| Aleksander Foryś | Q90702215 | ||
| P2093 | author name string | Suming Li | |
| P2860 | cites work | High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel | Q28548522 |
| A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro | Q30871548 | ||
| DDSolver: an add-in program for modeling and comparison of drug dissolution profiles | Q33550419 | ||
| Cellular mechanisms of multidrug resistance of tumor cells. | Q33854298 | ||
| Modeling and comparison of dissolution profiles | Q34215811 | ||
| Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters. | Q36143777 | ||
| Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases | Q37274044 | ||
| P-glycoprotein-activity measurements in multidrug resistant cell lines: single-cell versus single-well population fluorescence methods | Q37358540 | ||
| Microtubules and resistance to tubulin-binding agents | Q37690565 | ||
| Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies | Q37998748 | ||
| Emerging nanotherapeutic strategies in breast cancer | Q38161649 | ||
| Polymeric micelles: nanocarriers for cancer-targeted drug delivery | Q38202058 | ||
| Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance. | Q38246305 | ||
| The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade | Q38305824 | ||
| Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs. | Q38588547 | ||
| Recent advances in polymeric micelles for anti-cancer drug delivery | Q38690785 | ||
| In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles. | Q38735063 | ||
| ABC transporters as mediators of drug resistance and contributors to cancer cell biology. | Q38834784 | ||
| Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel. | Q38942353 | ||
| Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. | Q39863143 | ||
| Human mutations that confer paclitaxel resistance. | Q41769659 | ||
| Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers | Q46968315 | ||
| pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer | Q47104795 | ||
| Polymeric micelles: Basic research to clinical practice | Q48667283 | ||
| Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multice | Q49992953 | ||
| Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. | Q50792703 | ||
| Effect of polymer degradation on prolonged release of paclitaxel from filomicelles of polylactide/poly(ethylene glycol) block copolymers. | Q52776519 | ||
| Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties. | Q52862390 | ||
| Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters. | Q53475159 | ||
| Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery | Q57182917 | ||
| Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy | Q61697502 | ||
| Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance | Q64106949 | ||
| Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme | Q72685142 | ||
| Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8 | Q72710440 | ||
| Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer | Q86952613 | ||
| Bioresorbable filomicelles for targeted delivery of betulin derivative - In vitro study | Q90702218 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | paclitaxel | Q423762 |
| P577 | publication date | 2019-04-06 | |
| P1433 | published in | Pharmaceutics | Q27723332 |
| P1476 | title | Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells | |
| P478 | volume | 11 |
Search more.